Genomic approaches to understand and control the emergence of vancomycin resistant Enterococcus faecium (VREfm) in Australia. [ 2012 - 2015 ]

Research Grant

Researchers: Prof Paul Johnson (Principal investigator) ,  A/Pr Torsten Seemann ,  Prof Benjamin Howden ,  Prof Michael Lindsay Grayson ,  Prof Tim Stinear

Brief description VRE is a serious hospital superbug that has been increasing in many major hospitals around Australia, while at the same time MRSA (Golden Staph) infections have been decreasing. This project will find out why VRE is increasing by examining what happens to patients at a major Australian hospital from their time of admission to the onset of infection with VRE. At the end of the project we will have the first real understanding of how VRE is transmitted so we can develop effective infection control measures.

Funding Amount $AUD 756,163.74

Funding Scheme Project Grants

Notes Standard Project Grant